Cytek Biosciences, Inc. — Director's Dealing 2021

Jul 23, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Cytek BioSciences, Inc. (CTKB)
CIK: 0001831915
Period of Report: 2021-07-22

Reporting Person: Dion Gisele (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$4.71	2031-04-15	Common Stock (13333)		Direct

Footnotes

F1: The shares subject to the option vest as follows: 1/24th of the shares subject to the option shall vest monthly over two years from March 31, 2021.